Integrating miRNA profiling and machine learning for improved prostate cancer diagnosis
PCa diagnosis remains challenging, particularly in differentiating it from BPH, as both conditions share overlapping clinical features. The…
Why Myriad Genetics (MYGN) Shares Are Falling Today
Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 3.8% in the afternoon session after weakness in the…
Novel AI application diagnoses endocrine cancers with speed and accuracy
A novel artificial intelligence (AI) application capable of diagnosing endocrine cancers with speed and accuracy is being presented…